Closing Bell: Medicenna Therapeutics Corp down on Friday (MDNA)
Today in trading, shares of Medicenna Therapeutics Corp opened at $2.21 and closed at $2.26. It traded at a low of $2.14 to a high of $2.37.
The price shrank -0.88% from the previous day's close of $2.28.
During the day across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -1.37% at 5446.68, the Dow Jones Industrial Average closed -1.21% at 40347.97 and the Nasdaq Composite closed -2.30% at 17194.15.
Medicenna Therapeutics Corp has listed on the Toronto Stock Exchange (TSX) under the ticker MDNA.
A total of 81,146 shares was traded during the session, with total trades of 215. On average, Medicenna Therapeutics Corp has traded 88,950 shares over the last 5-days and 124,080 year-to-date.
The TSX market on the whole today saw 741 price advancers against 4,512 declines and 69 unchanged.
During the prior 52 weeks, MDNA.TO has traded as high as $2.98 (June 03,2024) and low as $0.22 (November 01,2023). Moreover, the shares have risen 296.49 percent in the last year, while this year, they have risen 438.10%.
Following today's trading, Medicenna Therapeutics Corp has a market capitalization of $170.50 million on a float of 74,779 shares outstanding. Its annual EPS is $-0.23.
Medicenna Therapeutics Corp is a TSX Biotechnology company headquartered in Toronto, CAN.
Based on 2.00 analysts, Medicenna Therapeutics Corp gets an average recommendation of "Strong Buy" according to Zacks. Currently, there are 2 buy ratings for the stock.
AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..
